169 related articles for article (PubMed ID: 24875939)
21. Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.
Chu KP; Murphy JD; La TH; Krakow TE; Iagaru A; Graves EE; Hsu A; Maxim PG; Loo B; Chang DT; Le QT
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1521-7. PubMed ID: 22270168
[TBL] [Abstract][Full Text] [Related]
22. Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy.
Seol YM; Kwon BR; Song MK; Choi YJ; Shin HJ; Chung JS; Cho GJ; Lee JC; Lee BJ; Wang SG; Kim HJ; Kim WT; Kim SJ; Yun EY
Acta Oncol; 2010; 49(2):201-8. PubMed ID: 20100156
[TBL] [Abstract][Full Text] [Related]
23. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
[TBL] [Abstract][Full Text] [Related]
24. Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
Marcus C; Ciarallo A; Tahari AK; Mena E; Koch W; Wahl RL; Kiess AP; Kang H; Subramaniam RM
J Nucl Med; 2014 Sep; 55(9):1411-6. PubMed ID: 24947059
[TBL] [Abstract][Full Text] [Related]
25. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
[TBL] [Abstract][Full Text] [Related]
26. Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.
Machtay M; Duan F; Siegel BA; Snyder BS; Gorelick JJ; Reddin JS; Munden R; Johnson DW; Wilf LH; DeNittis A; Sherwin N; Cho KH; Kim SK; Videtic G; Neumann DR; Komaki R; Macapinlac H; Bradley JD; Alavi A
J Clin Oncol; 2013 Oct; 31(30):3823-30. PubMed ID: 24043740
[TBL] [Abstract][Full Text] [Related]
27. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
[TBL] [Abstract][Full Text] [Related]
29. Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.
Nicolau UR; de Jesus VHF; Lima ENP; Alves MS; de Oliveira TB; Andrade LB; Silva VS; Bes PC; de Paiva TF; Calsavara VF; Guimarães APG; Cezana L; Barbosa PNVP; Porto GCLM; Pellizzon ACA; de Carvalho GB; Kowalski LP
PLoS One; 2018; 13(8):e0200823. PubMed ID: 30114190
[TBL] [Abstract][Full Text] [Related]
30. A PET/CT-Based Strategy Is a Stronger Predictor of Survival Than a Standard Imaging Strategy in Patients with Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2018 Apr; 59(4):575-581. PubMed ID: 28864630
[TBL] [Abstract][Full Text] [Related]
31.
Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
[TBL] [Abstract][Full Text] [Related]
32. Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer.
Coupe NA; Karikios D; Chong S; Yap J; Ng W; Merrett N; Lin M
Ann Nucl Med; 2014 Feb; 28(2):128-35. PubMed ID: 24297388
[TBL] [Abstract][Full Text] [Related]
33. Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.
Elit LM; Fyles AW; Gu CS; Pond GR; D'Souza D; Samant R; Anthes M; Thomas G; Filion M; Arsenault J; Dayes I; Whelan TJ; Gulenchyn KY; Metser U; Dhamanaskar K; Levine MN
JAMA Netw Open; 2018 Sep; 1(5):e182081. PubMed ID: 30646153
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N;
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
[TBL] [Abstract][Full Text] [Related]
35. Institutional clinical trial accrual volume and survival of patients with head and neck cancer.
Wuthrick EJ; Zhang Q; Machtay M; Rosenthal DI; Nguyen-Tan PF; Fortin A; Silverman CL; Raben A; Kim HE; Horwitz EM; Read NE; Harris J; Wu Q; Le QT; Gillison ML
J Clin Oncol; 2015 Jan; 33(2):156-64. PubMed ID: 25488965
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET.
Platek A; Mix M; Chowdhry V; Farrugia M; Lacombe MA; Bogart JA; Degraaf L; Iovoli A; Arshad H; Wooten K; Gupta V; Hicks WL; Platek ME; Hahn SS; Singh AK
PLoS One; 2020; 15(4):e0231042. PubMed ID: 32275670
[TBL] [Abstract][Full Text] [Related]
37. Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.
Passero VA; Branstetter BF; Shuai Y; Heron DE; Gibson MK; Lai SY; Kim SW; Grandis JR; Ferris RL; Johnson JT; Argiris A
Ann Oncol; 2010 Nov; 21(11):2278-2283. PubMed ID: 20430907
[TBL] [Abstract][Full Text] [Related]
38. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
Groheux D; Hindié E; Delord M; Giacchetti S; Hamy AS; de Bazelaire C; de Roquancourt A; Vercellino L; Toubert ME; Merlet P; Espié M
J Natl Cancer Inst; 2012 Dec; 104(24):1879-87. PubMed ID: 23243198
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
Wang HM; Cheng NM; Lee LY; Fang YH; Chang JT; Tsan DL; Ng SH; Liao CT; Yang LY; Yen TC
Int J Cancer; 2016 Feb; 138(3):731-8. PubMed ID: 26311121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
